HCPCS G0482 Fee Schedule

Medicare rates as of January 2026

HCPCS G0482 is classified under Procedures / Professional Services, in the Other Services subgroup.

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed

Key Fact	Detail
Service Type	Procedures / Professional Services Other Services
Common Revenue Codes	0300 0301Sign up to view all 4
Medicare Fee Schedule	$198.74 national lab fee schedule rate (2026)View Medicare rates for G0482
Medicaid Fee Schedule	$194.27 median of the 8 states in the free previewView Medicaid rates for G0482

National average reimbursement for HCPCS G0482 by major payers:

$141.30

BCBS / Anthem

$111.30

UnitedHealthcare

$181.79

Aetna

$148.15

Cigna

Compare published rates across providers.

Choose a payer to see a sample of rates for HCPCS G0482.

HCPCS G0482

5 of 25 sample ratesHigher to lower in this preview

William Westra
H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc
MDAnatomic Pathology & Clinical Pathology PhysicianNPI 1114953346Tax ID 59-3238640
$119.23Published rate
Kathrin Dvir
H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc
FLHematology & Oncology PhysicianNPI 1417441163Tax ID 59-3238640
$119.23Published rate
Ling Zhang
H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc
TXPhysical Medicine & Rehabilitation PhysicianNPI 1134328214Tax ID 59-3238640
$119.23Published rate
Matthew Wallace
H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc
MIMedical Physician AssistantNPI 1427321041Tax ID 59-3238640
$101.36Published rate
Ana Rica Nguyen
H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc
FLCertified Registered Nurse AnesthetistNPI 1346762069Tax ID 59-3238640
$101.36Published rate

Get a free rate benchmark for your specialty.

Choose your state and specialty to build a report from payer-published rates.

Build my free benchmark

Looking for other data?

Use market rates to prepare your payer proposal.

Rate Benchmarking

Compare your rates with similar providers.

Select a published rate, define comparable providers, and see where that rate falls in your market.

See a sample rate comparison

Payer Contract Negotiation

Draft a fee schedule renegotiation letter.

Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.

See a sample payer proposal

Summit Women's CareDenver, Colorado

September 2, 2026

Contracting Manager
UnitedHealthcare
Commercial PPO

Re: Request for fee schedule renegotiation

We request a formal review of our Commercial PPO fee schedule. The comparison below summarizes our current rate alongside published rates for comparable Denver-area practices.

Market evidence · CPT 59485

Current rate: $152.40
Market median: $147.00
Market position: 61st percentile

The comparison includes 1,284 published rates from 96 provider groups, scoped to OB/GYN providers in a professional, office-based setting.

We would welcome a discussion of our fee schedule and the supporting July 2026 market analysis. Please let us know a suitable time to review the comparison together.

Sincerely,
Summit Women's Care

Check published rates for your payer and codes.

Explore state-level rates by specialty

HCPCS G0482 vs. Other Other Services Codes

The table lists codes related to G0482. Select one to see its fee schedule.

Code	Description
G0481-HCPCS	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed
G0482-HCPCS	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed
G0483-HCPCS	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to GC/MS (any type, single or tandem) and LC/MS (any type, single or tandem and excluding immunoassays (e.g., IA, EIA, ELISA, EMIT, FPIA) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed

What is a fee schedule?

A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS G0482. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.

Understanding the G0482 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.

Factors that affect fee schedules

Medicare & Medicaid Rates

Government-set reimbursement amounts

Private Insurance Rates

Negotiated rates between providers and insurance companies

Geographic Location

Costs may be higher in urban areas.

Provider Type

Hospital providers may have different rates than private practice.

FREE SAMPLE MARKET COMPARISON

Let's review your payer contracts side-by-side with the market.

Bring your top codes (like HCPCS G0482) and we'll show you how you compare in 15 minutes or less.

Schedule a Demo

Frequently Asked Questions

Which revenue codes are billed with HCPCS G0482?

Hospital price transparency files list HCPCS G0482 under these revenue codes: 0300, 0301, 0309 and 0971. A revenue code names the hospital department or charge category for the line; it does not change what the service is.